期刊文献+

不同剂量卡维地洛对心肌梗死后大鼠左室重构及心肌细胞凋亡的影响 被引量:1

Effects of carvediloi at different dose on left ventricular(LV)remodeling and cardial myocyte apoptosis after myocardial infarction in rats
下载PDF
导出
摘要 目的观察不同剂量卡维地洛(CAR)对心肌梗死(MI)后大鼠左室重构及心肌细胞凋亡的影响。方法结扎大鼠冠状动脉前降支,随机分成三组:MI组,术后不用药,卡维地洛大剂量组(HCAR组),卡维地洛小剂量组(LCAR组),术后2d分别给予卡维地洛10 mg/kg和1.25 mg/kg。另外不手术不用药组为假手术组(SH组)。6周后测定左室重构指标及心肌细胞凋亡计数。结果卡维地洛用药组与MI组比较,左室重构明显改善,心肌细胞凋亡量明显减少,且有剂量依赖,大剂量组优于小剂量组。结论卡维地洛可改善AMI后大鼠的左室重构,并有剂量依赖性,减少心肌细胞凋亡可能是其重要因素之一。 Objective To assess the dosage-effect pattern of carvedilol on LV remodeling and apoptosis in myocytes after MI. Methods Sham operated rats(SH) were selected randomly before conduction of AMI. after conduction of AMI, the surviving rats were randomly assigned to one of the following groups : MI group (AMI without carvedilol) ;hige-dose carvedilol group (carvedilol 10mg/kg/day) and low-dose carvedilol group(1.25 mg/kg/day),at the end of 6-week therapy, parameters of LV remodeling and apoptosis were measured. Results Comparing to MI group, LV remodeling decreased significantly and apoptosis reduced in carvedilol group in a dosage-effect pattern. Conclusions Carvedilol prevented LV remodeling, and anti-apoptosis acteveties of carvedilol may play an important role in this progression.
出处 《中国分子心脏病学杂志》 CAS 2007年第6期332-334,共3页 Molecular Cardiology of China
关键词 卡维地洛 左室重构 凋亡 Carvedilol Left ventricular remodeling Apoptosis
  • 相关文献

参考文献11

  • 1[1]Weisman HF,Bush DE,Mannisi JA.Cellular mechanisms of MI espansion.Circulation,1998,78:186-201.
  • 2[2]Sharow VG,Sabbsh HN,Shimoyama H,et al.Evidence of cardiocyte apoptisis in myocardium of dogs with chronic heart failure.Am J Pathol,1996,148:141-149.
  • 3[3]DeBelder AJ,Radomski MW,Why JF,et al.Myocardial calciumindependent nitric oxide synthase activity is present in dilated cardiomyopathy,myocarditis,and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.Br Heart J,1995,74:426-430.
  • 4[4]Dhalla AK,Hill MF,Singal PK.Role of oxidative stress in transition of hypertrophy to heart failure.J Am Coll Cardiol,1996,28:506-514.
  • 5[5]Yue TL,Cheng HY,Lysko P,et al.Carvedilol,a new vasodilator and bea-adrenoceptor blocker antagonists is an antioxidant and free radical scavenger.J Pharmacol Exp Ther,1992,263:92-8.
  • 6[6]Yue TL,Liu T,Feuerstein G.Carvedilol,a new vasodilator and β-adrenoceptor antagonist,inhibits oxygen radical mediated lipid peroxidation in swine ventricular membranes.Pharmacol Comm,1992,1:27-35.
  • 7[7]Senior R,Sumit Basu MB,Chrstopher Kinsey,et al.Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction.Am Heart J,1999,137:646-652.
  • 8[8]Doughty RN,Whalley GA,Gamble G,et al.Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease.J Am Coll Cardiol,1997,29:1060-1066.
  • 9[9]Gilbert EM,Abraham WT,Olsen S,et al.Comparative hemodynamic,left ventricular functional,and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.Circulation,1996,94:2187-2125.
  • 10[10]Feuerstein GZ,Yue TL.Apoptosis and the heart.Basic Appl Myol,1996,6:221-225.

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部